Literature DB >> 26723980

Linear lesions may assist early diagnosis of neuromyelitis optica and longitudinally extensive transverse myelitis, two subtypes of NMOSD.

Wei Cai1, Sha Tan1, Lei Zhang2, Yilong Shan1, Yanqiang Wang3, Yinyao Lin1, Fangjing Zhou4, Bingjun Zhang1, Xiaoyu Chen1, Li Zhou1, Yuge Wang1, Xuehong Huang1, Xuejiao Men1, Haiyan Li1, Wei Qiu1, Xueqiang Hu1, Zhengqi Lu5.   

Abstract

PURPOSE: To investigate the relationship between linear lesions (LL) and the development of longitudinally extensive spinal cord lesions (LESCL) in Chinese patients with neuromyelitis optica or longitudinally extensive transverse myelitis.
METHOD: The clinical records of 143 patients with these conditions were reviewed. Forty-one patients with LL were divided into three groups according to the order of appearance of LL and LESCL (simultaneously [n=10], LL first [n=26], or LESCL first [n=5]). The remaining 102 patients without LL were used as a control group.
RESULTS: Patients who developed LL first demonstrated a lower annualized relapse rate than those in the simultaneous group (1.00 [0.23-10.00] vs. 4.38 [0.60-6.67], p=0.017) and the control group (1.00 [0.23-10.00] vs. 2.00 [0.24-10.00], p=0.007). Among all patients with LL, there were significantly more who developed them before LESCL than those who developed them after LESCL (p<0.001) or at the same time (p=0.008). The mean time before the appearance of LESCL was 9.0months (2-35months) in the 'LL-first' group, which was shorter than that in the control group (12months [1-60months], p=0.010). The rate of positivity for anti-aquaporin 4 IgG antibodies was higher in patients with LL compared with controls (90.24% vs. 64.71%, p=0.002).
CONCLUSION: LL may be a precursor to LESCL and assist early diagnosis of neuromyelitis optica and longitudinally extensive transverse myelitis.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Linear lesion; Longitudinally extensive spinal cord lesion; Longitudinally extensive transverse myelitis; Neuromyelitis optica; Neuromyelitis optica spectrum disorder

Mesh:

Substances:

Year:  2015        PMID: 26723980     DOI: 10.1016/j.jns.2015.11.040

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

Review 1.  Pattern Recognition of the Multiple Sclerosis Syndrome.

Authors:  Rana K Zabad; Renee Stewart; Kathleen M Healey
Journal:  Brain Sci       Date:  2017-10-24

Review 2.  Magnetic resonance imaging in neuromyelitis optica spectrum disorder.

Authors:  Laura Clarke; Simon Arnett; Kate Lilley; Jacky Liao; Sandeep Bhuta; Simon A Broadley
Journal:  Clin Exp Immunol       Date:  2021-07-06       Impact factor: 4.330

Review 3.  Magnetic Resonance Imaging and Clinical Features in Acute and Subacute Myelopathies.

Authors:  Stefan Weidauer; Marlies Wagner; Michael Nichtweiß
Journal:  Clin Neuroradiol       Date:  2017-06-30       Impact factor: 3.156

Review 4.  Remote but not Distant: a Review on Experimental Models and Clinical Trials in Remote Ischemic Conditioning as Potential Therapy in Ischemic Stroke.

Authors:  Inês Mollet; João Pedro Marto; Marcelo Mendonça; Miguel Viana Baptista; Helena L A Vieira
Journal:  Mol Neurobiol       Date:  2021-10-22       Impact factor: 5.682

Review 5.  Clinical and neuroimaging findings in MOGAD-MRI and OCT.

Authors:  Frederik Bartels; Angelo Lu; Frederike Cosima Oertel; Carsten Finke; Friedemann Paul; Claudia Chien
Journal:  Clin Exp Immunol       Date:  2021-07-18       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.